MERCK & CO. INC.
MRKNYSE🏆 #40 by market capEarnings Oct 29 · PreUS Equity
$130.34▼ $0.56 (−0.43%)
Live1h—
24h▼ 0.4%
7d▲ 1.8%
14d▼ 1.1%
30d▲ 5.6%
1y▲ 62.8%
🏦Market Cap
$321.90B
Large Cap
📈Revenue Growth (YoY)
+4.6%
Slowing
📊Gross Margin
77.3%
High
💵FCF Margin
21.2%
Strong
⚖️P/S Ratio
4.8x
Fair
Otter Score
56
Weak
📊
Analyst Ratings
Price
$130.34
Total
14
Raised
10
Lowered
0
Avg PT
$139.43
H / L
$155 / $113
| Institution | Action | Rating | From | To | % Change | Upside/Downside |
|---|---|---|---|---|---|---|
Scotiabank Merck & Co | Raised | Sector Outperform | 136.00 | 155.00 | +13.97% | +18.90% |
Barclays Merck & Co | Raised | Overweight | 140.00 | 150.00 | +7.14% | +15.10% |
Wells Fargo Merck & Co | Raised | Overweight | 145.00 | 150.00 | +3.45% | +15.10% |
Guggenheim Merck & Co | Raised | Buy | 145.00 | 146.00 | +0.69% | +12.00% |
Argus Research Merck & Co | Raised | Buy | 130.00 | 145.00 | +11.54% | +11.30% |
UBS Merck & Co | Raised | Buy | 130.00 | 145.00 | +11.54% | +11.30% |
BMO Capital Merck & Co | Raised | Outperform | 135.00 | 142.00 | +5.19% | +9.00% |
RBC Capital Merck & Co | Reiterated | Outperform | 142.00 | 142.00 | +0.00% | +9.00% |
B of A Securities Merck & Co | Raised | Buy | 130.00 | 141.00 | +8.46% | +8.20% |
JP Morgan Merck & Co | Raised | Overweight | 135.00 | 140.00 | +3.70% | +7.40% |
CICC Merck & Co | Initiated | Outperform | — | 138.00 | — | +5.90% |
Citigroup Merck & Co | Reiterated | Neutral | — | 125.00 | — | −4.10% |
Cantor Fitzgerald Merck & Co | Reiterated | Neutral | 120.00 | 120.00 | +0.00% | −7.90% |
Morgan Stanley Merck & Co | Raised | Equal-Weight | 112.00 | 113.00 | +0.89% | −13.30% |
One row per institution, most recent rating